Prescription drug · ANDA
Warfarin Sodium NDC 51655-620
Warfarin sodium 1 mg/1 · Tablet · Oral · Northwind Health Company, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51655-620-52 | 51655062052 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-620-52)Marketed from Jan 3, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Warfarin Sodium
- Generic name (nonproprietary)
- warfarin sodium
- Active ingredients
- Warfarin sodium — 1 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040616
- Marketing start
- Listing expires
- Other FDA classes
- Vitamin K Inhibitors (Mechanism)
- Identifiers
- Product ID 51655-620_4b81033f-d891-feb5-e063-6394a90a7538SPL ID 4b81033f-d891-feb5-e063-6394a90a7538SPL set ID f32d3578-0c90-567c-e053-2a95a90a23b8RxCUI 855288UNII 6153CWM0CL
- Pharmacologic class
- Vitamin K Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451655062052followed by a unit qualifier and the quantityPackage 51655-0620-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extension of the formed clot and…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040616
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Warfarin Sodium | Warfarin sodium 1 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1712 |
| Warfarin Sodium | Warfarin sodium 5 mg/1 | TabletOral | Bryant Ranch Prepack | 63629-8843 |
| Warfarin Sodium | Warfarin sodium 2 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1713 |
| Warfarin Sodium | Warfarin sodium 2 mg/1 | TabletOral | Northwind Health Company, LLC | 51655-993 |
| Warfarin Sodium | Warfarin sodium 2.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0348 |
| Warfarin Sodium | Warfarin sodium 5 mg/1 | TabletOral | Proficient Rx LP | 63187-674 |
| Warfarin Sodium | Warfarin sodium 2.5 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1714 |
| Warfarin Sodium | Warfarin sodium 4 mg/1 | TabletOral | A-S Medication Solutions | 50090-5390 |
| Warfarin Sodium | Warfarin sodium 1 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-0727 |
| Warfarin Sodium | Warfarin sodium 4 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1716 |
| Warfarin Sodium | Warfarin sodium 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-5439 |
| Warfarin Sodium | Warfarin sodium 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-5440 |
| Warfarin Sodium | Warfarin sodium 6 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1718 |
| Warfarin Sodium | Warfarin sodium 4 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-0452 |
| Warfarin Sodium | Warfarin sodium 2.5 mg/1 | TabletOral | Proficient Rx LP | 63187-745 |
| Warfarin Sodium | Warfarin sodium 10 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1720 |
| Warfarin Sodium | Warfarin sodium 7.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-1059 |
| Warfarin Sodium | Warfarin sodium 5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | 43063-176 |
| Warfarin Sodium | Warfarin sodium 10 mg/1 | TabletOral | Proficient Rx LP | 63187-750 |
| Warfarin Sodium | Warfarin sodium 5 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-1721 |
Showing 20 of 37.
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.